RNA-protein interactions reveal new coronavirus drug targets
A study led by researchers at the University of California San Diego School of Medicine and University of California, Riverside (UCR) School of Medicine has identified new targets for antiviral drugs against coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. These new targets could help scientists discover treatments that are less vulnerable to the rapid evolution of these…
A study led by researchers at the University of California, San Diego and UC Riverside has uncovered new RNA-protein interactions that could serve as potential drug targets against SARS-CoV-2, the virus responsible for COVID-19. By mapping these interactions, scientists aim to develop more effective antiviral treatments that are less likely to be resistant to viral mutations.
The research, published in Nature Communications, used an advanced technique called enhanced cross-linking and immunoprecipitation (eCLIP) to discover previously unknown interactions between SARS-CoV-2 RNA and key viral proteins. These interactions, if disrupted, could significantly reduce viral replication in both animal and human cells, offering a promising approach for combating COVID-19.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
